Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
about
Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's diseaseRed cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis.Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel diseaseHuman acetylator polymorphism: estimate of allele frequency in Libya and details of global distributionThe association of the slow acetylator phenotype with bladder cancer.Optimum dose of sulphasalazine for maintenance treatment in ulcerative colitis.Olsalazine versus placebo in the treatment of mild to moderate ulcerative colitis: a randomised double blind trial.The etiology and management of leukopenia.Agranulocytosis associated with sulphasalazine therapyMedical management of ulcerative colitis with a specific focus on 5-aminosalicylates.The long journey of salicylates in ulcerative colitis: The past and the future.Oral 5-aminosalicylic acid for maintenance of medically-induced remission in Crohn's disease.Influence of gut microflora on bioavailability.The effect of salicylazosulphapyridine (sulphasalazine) on male fertility. A review.Survey of the human acetylator polymorphism in spontaneous disorders.Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease.Effect of acetylator phenotype on efficacy and toxicity of sulphasalazine in rheumatoid arthritis.Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution.The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatientsThe effect of the acetylator phenotype on the metabolism of sulphasalazine in man.Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.A Modified Colorimetric Assay for Free and N4-Acetylated Sulfapyridine in Serum and Saliva after Sulfasalazine Administration
P2860
Q24245127-88C9E184-A350-4EA0-8323-61E8C2BA0B24Q28323157-02B2C254-C41B-4852-BBA5-828C2C9CF9ACQ33538523-2642CB71-6706-45F5-A9DA-331CDDFD96A5Q33562841-358631D0-C7EE-4885-91D4-081F7D6DBF91Q33668919-F331C5ED-E47C-4454-84EF-37BA52E02252Q33670806-3D1BE079-1334-4A56-85FC-7B1579B67B24Q34496962-FDC93C72-903C-463F-B8AB-B6517DD3EE5BQ34532732-6128BF2F-F6A8-461A-BBEE-401F91BB6F76Q36299368-7CCA86E4-7387-474B-B44D-B13685B3AE45Q36810281-8A16AA76-A319-4E2A-A62E-DAB86BD3D088Q38212225-B13E37FD-F4C8-4CD5-96B5-916305265816Q38571119-7A2B5E80-ECDC-412F-9BC2-CC74E14D8E56Q38967059-56D02787-926F-4F1C-8DEA-4774D4E1229FQ39274520-016AE5C5-47C7-4A25-A823-4213D3FAAF47Q39459955-8E7F6546-AE40-4D20-9400-1A148CA67269Q40190123-FCDCE969-7F0D-4AC2-B8E7-4B689762E2EAQ40845749-A5FAAE19-1846-475A-9888-5109956B6B5AQ41150439-75EDF3C1-C7D7-4848-B065-59B56DE022F9Q41834902-5E2EFF31-90A5-4919-8835-407B4268F2AFQ41839631-9F452005-7936-4235-BF5C-6B43A135ACC2Q42008549-EDFF7758-9A7A-4B8A-8DF5-10D81CED0F8BQ42847786-AEDA8EFD-9D34-4C3A-B26C-0C7925138811Q58148279-9ADFE193-2E99-4E73-931D-40A2E51BF792
P2860
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
description
1972 nî lūn-bûn
@nan
1972 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1972 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
name
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@ast
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@en
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@nl
type
label
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@ast
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@en
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@nl
prefLabel
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@ast
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@en
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@nl
P2860
P356
P1433
P1476
Acetylator phenotype and adverse effects of sulphasalazine in healthy subjects.
@en
P2093
P2860
P304
P356
10.1136/GUT.13.4.278
P407
P577
1972-04-01T00:00:00Z